68Ga-PSMA-HBED-CC在颈部、腹腔和骶部神经节的摄取是前列腺癌PET显像中的重要陷阱
该回顾性研究分析407例接受68Ga-PSMA-HBED-CC PET/CT的前列腺癌患者,发现98.5%患者存在交感干神经节生理性摄取,以腹腔神经节最高(平均SUVmax 2.9±0.8),且神经节多呈带状(71.2%),而淋巴结转移多呈结节状(58.6%),提示需结合摄取强度、位置和形态鉴别。
要点
- 68Ga-PSMA在颈部、腹腔和骶部交感神经节的生理性摄取常见,任何外周神经节摄取者占98.5%。
- 腹腔神经节摄取最高(平均SUVmax 2.9±0.8),高于颈部(2.4±0.6)和骶部(1.7±0.5)。
- 神经节多呈带状(71.2%),淋巴结转移多呈结节状(58.6%),形态有助于鉴别。
核心结论
- 68Ga-PSMA-HBED-CC PET所示交感干神经节摄取是前列腺癌PET显像中的重要陷阱。
- 腹腔神经节摄取高于颈部或骶部神经节,且摄取水平似乎与患者个体相关。
- 鉴别淋巴结转移与交感神经节时,应仔细检查摄取强度、确切位置和病灶形态。
研究设计与样本
- 回顾性分析407例接受68Ga-PSMA-HBED-CC PET(联合诊断性CT)的患者。
- 测定68Ga-PSMA PET阳性的颈部、腹腔和骶部神经节数量,并测量各神经节的形态和SUVmax。
- 同时测定相应区域(颈部、腹腔或骶部)相邻淋巴结转移灶的形态和SUVmax。
主要发现
- 任何外周神经节68Ga-PSMA配体摄取高于背景者401例(98.5%),颈部369例(92%),腹腔363例(89%),骶部183例(46%)。
- 腹腔神经节平均SUVmax 2.9±0.8,颈部2.4±0.6,骶部1.7±0.5,腹腔与颈部及骶部比较均P<0.0001。
- 个体内颈部与腹腔神经节摄取相关R=0.34(P<0.0001),颈部与骶部R=0.52(P<0.0001),腹腔与骶部R=0.16(P<0.05)。
- 相邻淋巴结转移摄取显著高于相应神经节:颈部18.0±16.2 vs 2.4±0.6,腹腔13.5±12.3 vs 2.9±0.8,骶部13.4±11.6 vs 1.7±0.5,均P<0.0001。
- 神经节形态以带状为主(71.2%),其次泪滴状(26.8%),结节状仅2.0%;淋巴结转移带状仅1.1%,泪滴状40.3%,结节状58.6%(P<0.00001)。
关键数值与推荐
- 神经节摄取高于背景定义为68Ga-PSMA配体摄取高于背景。
- 神经节形态分类:带状71.2%、泪滴状26.8%、结节状2.0%。
- 淋巴结转移形态分类:带状1.1%、泪滴状40.3%、结节状58.6%。
临床怎么用
- 原文结论指出,鉴别淋巴结转移与交感神经节时应仔细检查摄取强度、确切位置和病灶形态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The study aims to investigate the presence of physiologic prostate-specific membrane antigen (68Ga-PSMA)-ligand uptake on PET in cervical, celiac, and sacral ganglia of the sympathetic trunk as a pitfall for lymph node metastases in prostate cancer imaging. Methods: Four hundred seven patients who underwent Glu-NH-CO-NH-Lys radiolabeled with 68Ga-gallium N,N-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N-diacetic acid (68Ga-PSMA-HBED-CC) PET (combined with a diagnostic CT) were retrospectively analyzed. The number of 68Ga-PSMA PET-positive cervical, celiac, and sacral ganglia was determined, and the configuration and SUVmax of each ganglion were measured. In addition, the configuration and SUVmax of adjacent lymph node metastases in the respective region (cervical, celiac, or sacral) were determined. Results:68Ga-PSMA-ligand uptake above background was detected in 401 (98.5%) patients in any peripheral ganglia, in 369 (92%) patients in cervical ganglia, in 363 (89%) patients in celiac ganglia, and in 183 (46%) patients in sacral ganglia. The 68Ga-PSMA-ligand uptake was highest in celiac (mean SUVmax, 2.9 ± 0.8 vs. cervical mean SUVmax, 2.4 ± 0.6) and sacral (mean SUVmax 1.7 ± 0.5; both P < 0.0001) ganglia. Intraindividually there was a statistically significant but weak to moderate correlation between the 68Ga-PSMA-ligand uptake in cervical versus celiac ganglia (R = 0.34, P < 0.0001), cervical versus sacral (R = 0.52, P < 0.0001), and celiac versus sacral (R = 0.16, P < 0.05). The 68Ga-PSMA-ligand uptake was significantly more intense in adjacent lymph node metastases than the respective ganglia (cervical: 18.0 ± 16.2 vs. 2.4 ± 0.6, P < 0.0001; celiac: 13.5 ± 12.3 vs. 2.9 ± 0.8, P < 0.0001; sacral: 13.4 ± 11.6 vs. 1.7 ± 0.5, P < 0.0001). Furthermore, ganglia predominantly exhibit a band-shaped configuration (71.2%), followed by a teardrop (26.8%) and only rarely a nodular configuration (2.0%). Conversely, lymph node metastases are only rarely band-shaped (1.1%), but more often show teardrop (40.3%) or nodular appearance (58.6%) (P < 0.00001). Conclusion:68Ga-PSMA-ligand uptake in ganglia along the sympathetic trunk as assessed by 68Ga-PSMA-HBED-CC PET represents an important pitfall in prostate cancer PET imaging. The 68Ga-PSMA-ligand uptake is higher in celiac ganglia than cervical or sacral ganglia, and the level of 68Ga-PSMA-ligand uptake seems to be patient-related. For the differentiation between lymph node metastases and sympathetic ganglia, both intensity of 68Ga-PSMA-ligand uptake and exact localization and configuration of the respective lesion should be examined carefully.
引用
- Rischpler C, Beck TI, Okamoto S, et al. 68Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging. J Nucl Med. 2018. PMID: 29371407. doi:10.2967/jnumed.117.204677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。